Clinical trial

Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa

NCT02025868

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-03-01

PhasePHASE2

Study timeline

Study start (unknown)2013-03-01Date precision: month

Registry last updated2017-02-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionunresolved

Interventions

adherence reinforcementBEHAVIORAL

Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators)DRUG

Sponsors & collaborators

ANRS, Emerging Infectious Diseaseslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02025868 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.